“Prognostic value of pre-treatment routine hematological parameters in breast carcinoma: Advantageous or deleterious?”, Biomed. Res. Ther., vol. 7, no. 8, pp. 3916–3920, Aug. 2020, doi: 10.15419/bmrat.v7i8.621.